Latest Security News

OD6 Metals is progressing its acquisition option for the Quinn Fluorspar Project in Nevada, a high-grade fluorspar asset poised to address the United States' complete import reliance on this critical mineral vital to semiconductor, battery, and defense sectors.

Stelar Metals (ASX:SLB) is accelerating exploration at its Hill of Leaders Tungsten Project in the Northern Territory, aiming to capitalise on soaring tungsten prices and critical mineral demand driven by Chinese export restrictions.

Infratil Investments has inked a deal with Macquarie Securities to offload 53.5 million Contact Energy shares at NZ$9.25 each, trimming its stake slightly and unlocking nearly half a billion NZD.

Sarama Resources has raised A$1.5 million through a private placement to fund copper-gold exploration in New South Wales and support its US$242 million arbitration claim against Burkina Faso. The arbitration hearing is set for February 2027, while Sarama plans to retain significant equity in Riedel Resources following a major asset sale.

Flagship Minerals has secured A$2.75 million through a strategic placement led by long-term partners, poised to accelerate feasibility and technical work at its 2.1 million ounce Isidora Gold Project in Chile.

Ovanti Limited is proposing to issue over 520 million free-attaching options to recent placement investors and its lead manager, exercisable at $0.025 and expiring in 2030, pending shareholder approval.

Electro Optic Systems (ASX:EOS) has raised A$190 million through institutional and strategic placements at an 9.3% discount, alongside a planned A$25 million share purchase plan, to fund its MARSS acquisition and expand defence capabilities.

RAS Technology Holdings has locked in new contracts and extensions expected to add at least $2 million in annualised revenue, reinforcing growth in wagering technology and international markets.

MyEco Group has extended its partnership with Penrith City Council by winning a 3-to-5-year contract to supply compostable caddy liners for the council's FOGO program, aligning with NSW's mandated organics recycling rollout.

Mach7 Technologies has secured a five-year, A$1.7 million subscription contract with US teleradiology provider AMRADNET, slashing deployment time from 12 months to just 45 days.

Patrys has appointed CMAX and Alithia Life Sciences to lead its Phase 1A clinical trial operations for RLS-2202, advancing its injectable quetiapine program toward first-in-human testing in Q3 2026, pending ethics approval.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.